Kayne Anderson Rudnick Investment Management
OLMA icon

Kayne Anderson Rudnick Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-128
Closed -$1K – 658
2022
Q1 		$1K Buy
+128
New +$705 ﹤0.01% 639

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's OLMA Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2022, closing a stake of 128 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in OLMA in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 76 funds tracked by Wall St. Rank hold OLMA as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining Olema Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 128 Olema Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Olema Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's Olema Pharmaceuticals position peaked at $1K in Q1 2022.
  • 76 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.